These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6060954)

  • 1. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of amino-glutethimide on adrenal function in man.
    Fishman LM; Liddle GW; Island DP; Fleischer N; Küchel O
    J Clin Endocrinol Metab; 1967 Apr; 27(4):481-90. PubMed ID: 4290077
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1550-7. PubMed ID: 6075585
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP; Earll JM; Forsham PH
    Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm.
    Olsen NJ; Fang VS; DeGroot LJ
    Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI; Lemesheva SN
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cushing's syndrome: diagnostic value of hormone determinations and adrenal gammagraphy. Apropos of 21 patients].
    González Atienza J; Anglada Barceló J; Tresánchez Trías JM
    Med Clin (Barc); 1984 Mar; 82(9):388-91. PubMed ID: 6325835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J; Valette A; Latrabe J; Codaccioni JL
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent Cushing's syndrome with anomalous response to dexamethasone.
    Brooks RV; Jeffcoate SL; London DR; Prunty FT; Smith PM
    J Endocrinol; 1966 Sep; 36(1):53-61. PubMed ID: 4288409
    [No Abstract]   [Full Text] [Related]  

  • 10. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the frequency of peptic ulcer in cases of endogenous cortisol hypersecretion].
    Tafurt C
    Endokrinologie; 1967; 52(1):8-11. PubMed ID: 5585234
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's syndrome due to bilateral adrenocortical hyperplasia caused by a benign adrenal medullary tumor.
    Meloni CR; Tucci J; Canary JJ; Kyle LH
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1192-200. PubMed ID: 4288612
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.
    Faglia G; Gattinoni L; Travaglini P; Neri V; Acerbi L; Ambrosi B
    Metabolism; 1971 Mar; 20(3):266-72. PubMed ID: 5546922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of adrenocortical steroid production in therapy].
    Bricaire H; Philbert M; Luton JP
    Rev Fr Etud Clin Biol; 1968; 13(6):563-7. PubMed ID: 4178146
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.
    Krieger DT; Glick SM
    Am J Med; 1972 Jan; 52(1):25-40. PubMed ID: 5058357
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparative evaluation of the functional state of the adrenal cortex in puberty-juvenile dyspituitarism and Itsenko-Cushing disease (second report)].
    Egart FM; Lemesheva SN; Goncharova VN
    Probl Endokrinol (Mosk); 1973; 19(4):37-40. PubMed ID: 4788098
    [No Abstract]   [Full Text] [Related]  

  • 17. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

  • 18. The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives.
    Streeten DH; Stevenson CT; Dalakos TG; Nicholas JJ; Dennick LG; Fellerman H
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1191-211. PubMed ID: 5808526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recurrences following surgical treatment of Cushing's syndrome].
    Platowski J
    Pol Przegl Chir; 1971 Dec; 43(12):1877-80. PubMed ID: 4944772
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of cortisol in Cushing's syndrome.
    Ghosh PC; Pennington GW
    Steroids; 1969 Sep; 14(3):369-80. PubMed ID: 5821993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.